GR3006608T3 - - Google Patents

Info

Publication number
GR3006608T3
GR3006608T3 GR920403016T GR920403016T GR3006608T3 GR 3006608 T3 GR3006608 T3 GR 3006608T3 GR 920403016 T GR920403016 T GR 920403016T GR 920403016 T GR920403016 T GR 920403016T GR 3006608 T3 GR3006608 T3 GR 3006608T3
Authority
GR
Greece
Application number
GR920403016T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3006608T3 publication Critical patent/GR3006608T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR920403016T 1986-08-28 1992-12-21 GR3006608T3 (US08017358-20110913-P00015.png)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90125486A 1986-08-28 1986-08-28
US07/060,203 US4889862A (en) 1986-08-28 1987-06-10 Freeze-dried pharmaceutical compositions of phenylquinoline carboxylic acids

Publications (1)

Publication Number Publication Date
GR3006608T3 true GR3006608T3 (US08017358-20110913-P00015.png) 1993-06-30

Family

ID=26739681

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920403016T GR3006608T3 (US08017358-20110913-P00015.png) 1986-08-28 1992-12-21

Country Status (17)

Country Link
US (1) US4889862A (US08017358-20110913-P00015.png)
EP (1) EP0261426B1 (US08017358-20110913-P00015.png)
JP (1) JP2629005B2 (US08017358-20110913-P00015.png)
KR (1) KR950006218B1 (US08017358-20110913-P00015.png)
AU (1) AU602715B2 (US08017358-20110913-P00015.png)
CA (1) CA1312824C (US08017358-20110913-P00015.png)
DE (1) DE3782480T2 (US08017358-20110913-P00015.png)
DK (1) DK168655B1 (US08017358-20110913-P00015.png)
ES (1) ES2052530T3 (US08017358-20110913-P00015.png)
FI (1) FI90824C (US08017358-20110913-P00015.png)
GR (1) GR3006608T3 (US08017358-20110913-P00015.png)
HU (1) HU199289B (US08017358-20110913-P00015.png)
IE (1) IE60490B1 (US08017358-20110913-P00015.png)
IL (1) IL83662A (US08017358-20110913-P00015.png)
NO (1) NO873626L (US08017358-20110913-P00015.png)
NZ (1) NZ221574A (US08017358-20110913-P00015.png)
PT (1) PT85612B (US08017358-20110913-P00015.png)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861783A (en) * 1988-04-26 1989-08-29 E. I. Du Pont De Nemours And Company 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases
HU206975B (en) * 1991-03-14 1993-03-01 Reanal Finomvegyszergyar Process for producing granulation and veterinary composition comprising water-soluble flumequine complex
AU739673B2 (en) * 1997-02-05 2001-10-18 Kirin Pharma Kabushiki Kaisha Lyophilized compositions containing sphingoglycolipid and process for preparing them
US6417167B1 (en) 1997-02-05 2002-07-09 Kirin Beer Kabushiki Kaisha Lyophilized compositions containing shingoglycolipid and process for preparing them
TWI232102B (en) 2001-07-17 2005-05-11 Shionogi & Co A pharmaceutical formulation for injection
US20060008529A1 (en) * 2004-07-12 2006-01-12 Meyerhoff Mark E Use of additive sites to control nitric oxide release from nitric oxide donors contained within polymers
US20080241208A1 (en) * 2005-06-30 2008-10-02 Charles Shanley Methods, Compositions and Devices For Promoting Anglogenesis
WO2007064895A2 (en) * 2005-12-02 2007-06-07 The Regents Of The University Of Michigan Polymer compositions, coatings and devices, and methods of making and using the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US468299A (en) * 1892-02-02 John atkinson
DE433646C (de) * 1923-09-15 1926-09-09 Chem Fab Vorm E Schering Verfahren zur Herstellung in Wasser leicht loeslicher Derivate von Carbonsaeuren derChinolin- und Pyridinreihe
US3681495A (en) * 1969-08-25 1972-08-01 American Home Prod Freeze dried echothiophate iodide compositions
JPS5071816A (US08017358-20110913-P00015.png) * 1973-11-02 1975-06-14
US4036954A (en) * 1973-11-02 1977-07-19 Yamanouchi Pharmaceutical Co., Ltd. Stable prostaglandin E group-containing formulation
AT356278B (de) * 1976-07-12 1980-04-25 Hoffmann La Roche Verfahren zur herstellung von injektions- loesungen
JPS5976017A (ja) * 1983-01-20 1984-04-28 Yamanouchi Pharmaceut Co Ltd 安定なプロスタグランジンe類製剤の製法
CA1288436C (en) * 1983-07-22 1991-09-03 David Paul Hesson Phenylquinolinecarboxylic acids and derivatives as antitumor agents
US4680299A (en) * 1984-04-30 1987-07-14 E.I. Du Pont De Nemours And Company 2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereof
DE3329952A1 (de) * 1983-08-19 1985-02-28 Behringwerke Ag, 3550 Marburg Verfahren zur verringerung einer truebung in kontrollseren
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs

Also Published As

Publication number Publication date
AU602715B2 (en) 1990-10-25
DE3782480T2 (de) 1993-04-08
ES2052530T3 (es) 1994-07-16
FI90824C (fi) 1994-04-11
DK447887D0 (da) 1987-08-27
CA1312824C (en) 1993-01-19
EP0261426A1 (en) 1988-03-30
NO873626L (no) 1988-02-29
IL83662A (en) 1991-09-16
FI873701A0 (fi) 1987-08-26
FI873701A (fi) 1988-02-29
FI90824B (fi) 1993-12-31
IE60490B1 (en) 1994-07-27
HUT45398A (en) 1988-07-28
IL83662A0 (en) 1988-01-31
JP2629005B2 (ja) 1997-07-09
NZ221574A (en) 1989-11-28
JPS63115816A (ja) 1988-05-20
DE3782480D1 (de) 1992-12-10
DK447887A (da) 1988-02-29
NO873626D0 (no) 1987-08-27
EP0261426B1 (en) 1992-11-04
KR950006218B1 (ko) 1995-06-12
DK168655B1 (da) 1994-05-16
US4889862A (en) 1989-12-26
IE872290L (en) 1988-02-28
PT85612B (pt) 1990-05-31
AU7762287A (en) 1988-03-03
PT85612A (en) 1987-09-01
HU199289B (en) 1990-02-28
KR880002507A (ko) 1988-05-09

Similar Documents

Publication Publication Date Title
IN170757B (US08017358-20110913-P00015.png)
CH676533GA3 (US08017358-20110913-P00015.png)
IN170532B (US08017358-20110913-P00015.png)
IN169970B (US08017358-20110913-P00015.png)
IN164200B (US08017358-20110913-P00015.png)
DE8705495U1 (US08017358-20110913-P00015.png)
IN170025B (US08017358-20110913-P00015.png)
CH677995GA3 (US08017358-20110913-P00015.png)
DE8630122U1 (US08017358-20110913-P00015.png)
DE8712449U1 (US08017358-20110913-P00015.png)
DE8633791U1 (US08017358-20110913-P00015.png)
IN169102B (US08017358-20110913-P00015.png)
AU5703286A (US08017358-20110913-P00015.png)
AU5940986A (US08017358-20110913-P00015.png)
BE905208A (US08017358-20110913-P00015.png)
DE8632125U1 (US08017358-20110913-P00015.png)
AU5558386A (US08017358-20110913-P00015.png)
AU6014586A (US08017358-20110913-P00015.png)
DE8632722U1 (US08017358-20110913-P00015.png)
AU5597686A (US08017358-20110913-P00015.png)
DE8706472U1 (US08017358-20110913-P00015.png)
AU5878886A (US08017358-20110913-P00015.png)
AU5767086A (US08017358-20110913-P00015.png)
AU6011386A (US08017358-20110913-P00015.png)
AU6211586A (US08017358-20110913-P00015.png)